Entry |
|
Name |
Thrombin alfa (USAN/INN) |
Formula |
C1511H2342N418O436S15
|
Exact mass |
33798.975
|
Mol weight |
33820.2772
|
Sequence |
(Light chain) TFGSGEADCG LRPLFEKKSL EDKTERELLE SYIDGR (Heavy chain) IVEGSDAEIG MSPWQVMLFR KSPQELLCGA SLISDRWVLT AAHCLLYPPW DKNFTENDLL VRIGKHSRTR YERNIEKISM LEKIYIHPRY NWRENLDRDI ALMKLKKPVA FSDYIHPVCL PDRETAASLL QAGYKGRVTG WGNLKETWTA NVGKGQPSVL QVVNLPIVER PVCKDSTRIR ITDNMFCAGY KPDEGKRGDA CEGDSGGPFV MKSPFNNRWY QMGIVSWGEG CDRDGKYGFY THVFRLKKWI QKVIDQFGE (Disulfide bridge: L9-H119, H28-H44, H173-H187, H201-H231) |
Type |
Peptide |
Class |
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
|
Remark |
Product (DG00169): | D00090<JP/US> |
|
Efficacy |
Blood coagulation factor (enzyme), Hemostatic |
Comment |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BC Local hemostatics
B02BC06 Thrombin
D09016 Thrombin alfa (USAN/INN)
B02BD Blood coagulation factors
B02BD30 Thrombin
D09016 Thrombin alfa (USAN/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG00169 Thrombin
D09016 Thrombin alfa
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG00169 Thrombin
|
Other DBs |
|
LinkDB |
|